サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513986

臨床診断オートメーションの世界市場

Clinical Diagnostics Automation

出版日
ページ情報
英文 199 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
臨床診断オートメーションの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

臨床診断オートメーションの世界市場は2030年までに83億米ドルに到達

2023年に53億米ドルと推定される臨床診断オートメーションの世界市場は、2030年には83億米ドルに達し、分析期間2023-2030年のCAGRは6.6%で成長すると予測されます。

米国市場は14億米ドル、中国はCAGR 10.7％で成長予測

米国の臨床診断オートメーション市場は2023年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに19億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4％と6.9％と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界のコンピュータ支援検出（CAD）市場- 主要動向と促進要因のまとめ

高度なアルゴリズムと機械学習を活用したコンピュータ支援検出（CAD）システムは、医療画像を解釈し、さまざまな医療分野で診断精度を高める上で重要な役割を果たしています。これらのシステムは、X線、MRI、内視鏡、超音波などの画像から潜在的な異常を特定することで放射線科医を支援し、重要な診断支援を提供します。人工知能などの高度な技術の統合により、CADシステムはデジタル病理学、予防検診、緊急診断などの分野でますます不可欠なものとなっています。これらのシステムに対する需要の高まりは、特にがんのような複雑な領域において、早期発見と正確な診断をサポートすることによって患者の転帰を改善する能力によってもたらされています。

マンモグラフィやMRIなどの医療用画像処理技術の技術的進歩は、がんの有病率の上昇と相まって、CAD市場の主な促進要因となっています。これらの改良により、より精密で高解像度の画像が得られるようになり、CADソフトウェアがより正確な分析を行えるようになった。さらに、ヘルスケアにおけるクラウドコンピューティングへのシフトは、ITコストの削減と医療従事者間のコラボレーション強化を提供する、スケーラブルでアクセス可能なCADソリューションの開発を可能にしました。さまざまな診断機器からの画像を解析できるマルチモダリティCADシステムの動向は、診断精度と患者の転帰をさらに向上させる。

CADシステムにおけるAIの統合は、膨大なデータセットから学習し、がんなどの疾患を示す複雑なパターンや異常を認識するツールを提供し、医療画像診断における重要な進化を示すものです。このAIの統合は、診断を迅速化し、ヒューマンエラーを減少させ、予防ヘルスケアと早期診断に重点を置くようになっています。一般的な画像診断にとどまらず、CADシステムは、大腸内視鏡検査におけるポリープや、呼吸器内科における肺結節といった疾患の検出に特化した用途も見出しています。CADの技術革新はデジタル病理学分野にも進出しており、現在進行中の調査では、免疫染色だけでなく、標準的なH&E染色の分析など、より広範な診断作業への応用が拡大しており、将来の医療行為に大きな影響を与える可能性を強調しています。

調査対象企業の例（全54件）

  • Abaxis Inc.
  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Diagnostica Stago
  • Eppendorf AG
  • HORIBA ABX SAS
  • Hudson Robotics Inc.
  • Ortho Clinical Diagnostics Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers
  • Sysmex America Inc.
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6034

Global Clinical Diagnostics Automation Market to Reach US$8.3 Billion by 2030

The global market for Clinical Diagnostics Automation estimated at US$5.3 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.7% CAGR

The Clinical Diagnostics Automation market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

Select Competitors (Total 54 Featured) -

  • Abaxis Inc.
  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Diagnostica Stago
  • Eppendorf AG
  • HORIBA ABX SAS
  • Hudson Robotics Inc.
  • Ortho Clinical Diagnostics Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers
  • Sysmex America Inc.
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Clinical Diagnostics Automation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Investments in Biotechnology - A Key Growth Driver
    • Microplate instrumentation - An Integral Component of Lab Automation Market
    • Modular Automation Surges Ahead of TLA in Adoption
    • Automation in Immunohistochemistry offers High Throughput Capabilities
    • Demand for Automated Hematology Analyzers on Rise
    • Automated Multiplexing Technology and its Role in Clinical Diagnostics Automation
    • Laboratory Information System - A Key Aspect of Clinical Diagnostics Automation
    • Increasing Demand for High-throughput Testing Drives Clinical Diagnostics Automation Market Growth
    • Growth in Molecular Diagnostics Strengthens Business Case for Automation
    • Integration of AI and Robotics in Diagnostics Automation Throws Spotlight on Innovation
    • Rising Investments in Healthcare Infrastructure Expands Market Horizons
    • Development of Integrated Diagnostics Platforms Strengthens Market Position
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Clinical Diagnostics Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Clinical Diagnostics Automation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • CHINA
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Clinical Diagnostics Automation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • INDIA
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Clinical Diagnostics Automation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Clinical Diagnostics Automation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Clinical Diagnostics Automation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Clinical Diagnostics Automation by Segment - Clinical Diagnostics Automation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR

IV. COMPETITION